Matthew P Goetz

35PUBLICATIONS
296CO-AUTHORS
Proteins and peptidesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Oct 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.

Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel

|Oct 02, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

|Aug 28, 2025
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".

Matthew P Goetz, Grace M Choong, Tanya L Hoskin

|Apr 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.

Grace M Choong, Tanya L Hoskin, Judy C Boughey

Pageof 6